BioIVT, a leading provider of biospecimens, research models and services for drug and diagnostic development, today announced that the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has chosen it to supply biosamples for the Neurofilament as a Blood-Based Biomarker of Neurodegeneration in Familial Frontotemporal Degeneration (FTD) Project.

Potential UK draft legislation to scrap the Protocol has been reported in the media. The EU has called for honesty and a climb-down in rhetoric on the issue.

The adjournment debate secured by Neale Hanvey MP followed discussion in the Main Chamber about the Queen’s Speech and covered the UK diagnostics industry’s experience of the pandemic and what can be learned in future.

A total of 38 draft Bills and Bills are on the agenda in the upcoming Government session, including the important Procurement Bill.

LSG has recently completed a move to new, larger facilities in Sandy, Bedfordshire. The facilities will offer expanded manufacturing capabilities available in new cleanroom suites equipped to GMP standards.

The move could be a game-changer for cancer researchers in their mission to use data to develop improved treatments and patient care

The last 12 months have seen nearly three million people referred for lifesaving cancer checks – an all-time record

This new test could save the lives of countless babies and save the sight of many others

The UK Government announced new trade measures to support Ukraine following Russia’s invasion of Ukraine. These include: •    The removal of tariffs on all goods from Ukraine, providing economic support; •    New export ban on products and technology that Russia could use to repress the people of Ukraine. These could include interception and monitoring equipment;These tariff measures are part of broad UK economic support to Ukraine, includi...

BIVDA, the UK’s in vitro diagnostics trade association, has commented on the passing of the Health and Care Bill into law which took place yesterday.  Our 200+ IVD member companies supply or support key diagnostic technologies and stand-alone products to the NHS. Stability of these supply chains, commissioning processes and specifics regarding purchase tenders are critical factors to the protection of UK diagnostic care and optimised patient outcomes.  We support the integration ...